Yvette Aldrich

Principal Clinical Research Associate at Visus Therapeutics

Yvette brings over 20 years of experience in the research arena, mostly within ophthalmology, but also has experience in oncology, device, cardiac and gene therapy.

In her 8 years at Alcon, Yvette worked as a principal CRA and a lead on surgical studies. Yvette also previously worked at Allergan, in her 8 years there she worked on retina and anterior segment studies, with a key focus on presbyopia trials. Prior to Yvette’s start in research, she worked with a medical school professor on a differential diagnosis program, (KBIT), that is being used in medical schools today, and later moved into a position as a study coordinator on pharma industry oncology studies. Yvette progressed into monitoring oncology, and then into ophthalmology at Alcon in 2003.

Location

Carrollton, United States

Links


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Visus Therapeutics

Visus Therapeutics is a clinical-stage company in pursuit of developing the world’s first presbyopia-correcting eye drop with the potential to last at least eight hours.


Industries

Employees

11-50

Links